Medications

Stakes are high ahead of FDA panel vote on ALS drug

Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.

Neuroscience

NFL players face 4 times the odds of ALS

NFL players are four times more likely to die of Lou Gehrig's disease (ALS) than other people, new research finds, adding to known links between football-related head injuries and brain diseases, including Alzheimer's, Parkinson's ...

page 2 from 6